Cytokinetics (CYTK) executive compensation, 2026 proxy

Robert I. Blum, Principal Executive Officer, was paid $11.9M in 2025, down 17% from $14.4M the year before. The CEO-to-median-employee pay ratio was 28:1, on median employee pay of $425,718.

Filed
April 17, 2026
Annual meeting
May 27, 2026
Pay year
2025
Named executives
5
CEO total pay
$11.9M-17% vs prior year
CEO to median employee
28:1median $425,718
CEO pay in equity
86%$10.2M in awards
CEO Target Bonus
$772,715Non-equity incentive plan target
Sign-on Bonus
$200,000For Jeffrey Hessekiel
Median Employee Pay
$425,718Annual total compensation

How Blum was paid

$11.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Stock awards43%Option awards43%Non-equity incentive7%All other compensation0%

Named executive officers

ExecutiveTotal
Robert I. BlumPrincipal Executive Officer$11,881,456
Andrew M. CallosExecutive Vice President, Chief Commercial Officer$3,787,644
Jeffrey HessekielExecutive Vice President, Chief Legal & Administrative Officer$6,086,217
Sung H. LeePrincipal Financial Officer$3,770,807
Fady I. MalikExecutive Vice President, Research and Development$4,467,066

What changed and why

  • $11.9MCEO total compensation decreased to $11,881,456 in 2025 compared to $14,363,456 in 2024.
  • No PSUs were granted to named executive officers in 2025.
  • $200KJeffrey Hessekiel received a sign-on bonus of $200,000 upon joining the company in November 2025.
  • The CEO to median employee pay ratio was 28 to 1 for fiscal year 2025.
  • $5.1MOption awards for the CEO were valued at $5,095,918 using the grant date fair value method.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.